MSF Foundation Supports Epicentre in New Yellow Fever Study
Share
Share on Facebook
Share on Telegram
Share on LinkedIn
Share on Twitter
Copy link
Page url is copied
The study began in July 2017. It will enroll 960 participants supported at Epicentre's research center in Mbarara, Uganda, and the Kilifi Medical Research Institute in Kenya.
The Optimilk F-60 project has reached a key milestone: the first children have been enrolled in the Phase 1 clinical trial evaluating the safety and tolerability of F-60, a new therapeuti...
Incontinence, prolapse, pain: for many women, these conditions remain hidden due to a lack of appropriate care.
In Bamyan province, Afghanistan, the mountains and weather condition...
